Home Silk Road Medical Inc.

Silk Road Medical Inc.

VEITHsymposium: Favorable Outcomes with TCAR vs. Carotid Endarterectomy in Patients with Carotid Artery Disease

In a headline presentation, Dr. Mahmoud Malas of the University of California, San Diego School of Medicine shared updated results for the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project contemporaneously comparing TCAR to the surgical standard of care, carotid endarterectomy (CEA).

ROADSTER-2 Demonstrates Compelling Patient Outcomes with Strong Safety Profile

Final Results Presented during the late-breaking session at the Society for Vascular Surgery Annual Meeting

TCAR Achieves Favorable Outcomes vs. Carotid Endarterectomy in Patients with Carotid Artery Disease

The TCAR Surveillance Project, a key initiative of the Society for Vascular Surgery’s Vascular Quality Initiative (VQI), is an open-ended registry intended to compare real-world patient outcomes between TCAR and CEA.

TCAR Presentations to Take Place at the Society for Vascular Surgery 2019 Vascular Annual Meeting

Key data from the SVS TCAR Surveillance Project and ROADSTER-2 study will be presented at the upcoming Society for Vascular Surgery 2019 Vascular Annual Meeting (VAM), June 12-15 at the Gaylord National Resort & Convention Center in National Harbor, Maryland.

Silk Road Medical Traded its First Shares this Morning on Nasdaq: (SILK)

Silk Road Medical is focused on reducing the risk of stroke by treating carotid artery disease – a condition that affects more than 4 million people in the U.S. and is estimated to be the primary cause of up to one-third of strokes.

Silk Road Medical Announces Key TCAR Presentations at 2018 VEITHsymposium New York City

Silk Road Medical reports multiple podium presentations at the upcoming VEITHsymposium Nov. 13-17 at the New York Hilton-Midtown will feature the company’s TransCarotid Artery Revascularization (TCAR) procedure.

Trans Carotid Artery Revascularization (TCAR) Presentations and Data at the Annual Society for Vascular Surgery Meeting Makes POSITIVE Impact

Medical Device News Magazine interviewed two leading Vascular Surgeons who presented compelling talks on Trans Carotid Artery Revascularization (TCAR) at the Annual Meeting of the Society for Vascular Surgery Meeting held June 20 – 23, 2018 in Boston, MA.

Updated TCAR Data from Silk Road Medical’s ROADSTER 1 and 2 Studies Presented at VEITHsymposium

“TCAR is the next step,” said Dr. Peter Schneider, Chief of Vascular Therapy at Hawaii Permanente Medical Group and Kaiser Foundation Hospital Honolulu, and National Co-Principal Investigator of the ROADSTER 2 post-market study. “Carotid endarterectomy has been perfected over 50 years, but no matter how good it gets, it has certain inherent challenges that aren’t ever going to go away. My attitude now has really flip-flopped from that of tried and true surgery to what I think is the future of carotid artery repair.”